Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Adding Triamcinolone Does Not Improve Outcome of Migraine Therapy
Link ID 5038
Title Adding Triamcinolone Does Not Improve Outcome of Migraine Therapy
Url http://www.medscape.com/viewarticle/573250?src=rss
Description Adding triamcinolone to local anesthetics does not increase the efficacy of greater occipital nerve (GON) block and trigger-point injections for treatment of transformed migraine, researchers report in the April issue of the Journal of Neurology, Neurosurgery and Psychiatry. Reuters Health Information
Category Articles > Pharmacists
Keywords
Date Apr 19, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Pharmacists
1. Pfizer Wins Ruling That May Limit Celebrex Suits
  Pfizer Inc has won a U.S. court ruling that could limit the lawsuits claiming that its Celebrex painkiller caused heart attacks and strokes. Reuters Health Information
Category:   Articles > Pharmacists


2. Prescribing Factors and Patient Adherence Affect Cancer Pain Management
  Inadequate analgesic prescriptions and poor patient adherence contribute to ineffective cancer pain management, according to findings published in the November issue of the Journal of Pain and Symptom Management. Reuters Health Information
Category:   Articles > Pharmacists


3. Migraine Prophylaxis With Nebivolol Has Few Side Effects
  Nebivolol is as effective as metoprolol in the prevention of migraine attacks, but nebivolol is better tolerated and does not require as much dosage adjustment to reach therapeutic levels, researchers in Germany report. Reuters Health Information
Category:   Articles > Pharmacists


4. Profound Hypocitraturia Follows Topiramate Therapy
  Topiramate therapy can induce profound declines in urinary citrate levels, which may lead to urinary stones, according to a report in the July issue of Urology. Reuters Health Information
Category:   Articles > Pharmacists


5. High-Dose Erythropoietin Safe for Very Preterm Infants
  High-dose recombinant erythropoietin is well tolerated and can be safely given to very preterm infants, according to the results of two studies in the August issue of Pediatrics. Reuters Health Information
Category:   Articles > Pharmacists




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS